Equillium, Inc. Profile Avatar - Palmy Investing

Equillium, Inc.

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clin…

Biotechnology
US, La Jolla [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of EQ's Analysis
CIK: 1746466 CUSIP: 29446K106 ISIN: US29446K1060 LEI: - UEI: -
Secondary Listings
EQ has no secondary listings inside our databases.